Designed for those who want real, sustainable results—our GLP-1/GIP treatments work at the hormonal level to regulate appetite, optimize metabolism, and support fat loss. Whether your goal is to shed stubborn weight, improve energy, or maintain lean muscle, these science-backed therapies help you take control of your body, feel lighter, and perform at your best every day.
GLP-1 / GIP medications are clinically proven to support weight loss by regulating appetite and improving metabolic function. Our personalized approach connects you with licensed medical providers who tailor your treatment plan to your unique needs. With convenient weekly dosing and medications delivered to your door, achieving your goals has never been more accessible.
Enjoy the benefits of GLP-1 therapy without the injections. Oral Semaglutide offers convenience, that helps control appetite, support weight loss, and improve blood sugar levels. With a personalized plan guided by licensed providers and delivered discreetly to your door, it’s never been easier to take control of your health.
FDA-approved for the treatment of type 2 diabetes and improved glycemic control.
Ozempic is a weekly injectable medication designed to help adults with type 2 diabetes manage blood sugar levels. It also supports weight loss by reducing appetite and slowing digestion. The active ingredient, semaglutide, is a GLP-1 receptor agonist that mimics a natural hormone in the body.
FDA-approved for weight management for patients with obesity or overweight and related conditions.
Wegovy is a weekly injectable medication that helps adults with obesity or weight-related conditions lose and manage weight. The active ingredient, semaglutide, is a GLP-1 receptor agonist that reduces appetite and increases feelings of fullness.
FDA-approved for weight management in adults with obesity or overweight and related conditions.
Zepbound is a weekly injectable medication containing tripeptide, a dual GIP and GLP-1 receptor agonist. When used with lifestyle changes, it reduces appetite, increases feelings of fullness, and supports long-term weight loss.
FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Mounjaro is a weekly injection that contains tirzepatide, a dual GIP and GLP-1 receptor agonist. It is approved for type 2 diabetes and works by activating both receptors to reduce appetite and support weight loss.
People lost an average of 15% (up to 20%) bodyweight in a 68-week clinical study of GLP-1 / GIP medications.
*After 68 weeks, participants administering once-weekly semaglutide treatment experienced an average of 14.9%% reduction in body weight. (Source)
**Along with a reduced calorie diet and increased exercise. In a 72-week clinical study of tirzeaptide, adults with obesity and weight-related medical problems achieved 20.9% weight loss. (Source)
Ditch the quick fixes. Our expert-guided programs focus on sustainable, science-backed steps toward real, lasting change.
You’re not broken—your biology just needs support. We help you cut through the confusion and get to the root of what’s holding you back.
Feel like you again. More energy, more clarity, more confidence—so you can show up fully in life and do what you love.
Whether you’re managing risk or ready to level up, our holistic approach helps you look, feel, and live better—long term.
Answer a few quick questions about your health, lifestyle, and goals. It’s fast, secure, and reviewed by licensed professionals.
Your provider reviews your intake and, if appropriate, prescribes the treatment best suited to your needs — all online.
Your prescription is cold-shipped directly to your door in discreet packaging. Enjoy ongoing care and support every step of the way.
Select your medication type and weight to estimate average loss.
© 2025, Lifted Health. All rights reserved
© 2025, Lifted Health. All rights reserved
